Genmab — Januar 2023
-
God morgen. Ønsker alle på PI et godt og lykkebringende 2023
-
Go´ formiddag...med eller uden tømmermænd;-)
-
-
-
Interessant artikel om CAR-T contra Bispecific Antibodies, Godt nytår ! https://themmrf.org/2022/12/28/answers-to-faqs-from-our-12-20-22-expert-session-on-myeloma-highlights-from-the-ash-2022-meeting/
-
Godmorgen
-
Genmab-topchef: Tre kræftmidler er på vej mod væsentlige milepæle i 2023 - https://medwatch.dk/Medicinal___Biotek/article14766808.ece - godt nytår
-
En lille nyhed, som ikke er nævnt fra før nytår. FDA godkender kræftmiddel fra Roche https://medwatch.dk/Medicinal___Biotek/article14761309.ece
-
Eyes have been opened to the Genmab-Biontech collaboration, says CEO
The companies’ partnership is moving into a ”more promising phase,” and investors have begun to pay attention, says Genmab CEO Jan van de Winkel while championing the collaborative approach.
(medwatch.com)
-
Genmab to Present at the 41st Annual J.P. Morgan Healthcare Conference https://www.proinvestor.com/investornyt/922129/genmab-to-present-at-the-41st-annual-jp-morgan-healthcare-conference
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind